Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Long-Term Deferred Tax (2020 - 2025)

Historic Long-Term Deferred Tax for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $17.0 million.

  • Privia Health's Long-Term Deferred Tax fell 3816.97% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 3816.97%. This contributed to the annual value of $26.4 million for FY2024, which is 2504.83% down from last year.
  • According to the latest figures from Q3 2025, Privia Health's Long-Term Deferred Tax is $17.0 million, which was down 3816.97% from $23.7 million recorded in Q2 2025.
  • Over the past 5 years, Privia Health's Long-Term Deferred Tax peaked at $40.4 million during Q4 2022, and registered a low of $3.0 million during Q1 2021.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $27.1 million (2022), whereas its average is $28.0 million.
  • Per our database at Business Quant, Privia Health's Long-Term Deferred Tax soared by 81622.08% in 2022 and then crashed by 3816.97% in 2025.
  • Quarter analysis of 5 years shows Privia Health's Long-Term Deferred Tax stood at $33.4 million in 2021, then grew by 20.99% to $40.4 million in 2022, then decreased by 12.8% to $35.2 million in 2023, then dropped by 25.05% to $26.4 million in 2024, then plummeted by 35.39% to $17.0 million in 2025.
  • Its Long-Term Deferred Tax was $17.0 million in Q3 2025, compared to $23.7 million in Q2 2025 and $24.7 million in Q1 2025.